According to the latest report by IMARC Group “Cell Isolation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global cell isolation market size reached US$ 10.3 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 24.6 Billion by 2027, exhibiting a growth rate (CAGR) of 15.65% during 2022-2027.
Cell isolation, also known as cell separation, identifies, isolates and separates targeted cells from a heterogeneous mixture of a cell population. This process helps minimize experimental complexity, reduce the interference from other cell types, and diagnose diseases, cellular research and therapies. In recent years, cell separation has gained prominence as it plays a vital role in therapeutic protein production, in-vitro diagnostics and biologics designing.
Request for a free sample copy of this report:
The global cell isolation market is primarily driven by the expanding medical and pharmaceutical industry. Due to this, pharmaceutical manufacturers are using cell isolation technologies to develop drugs with improved efficacies. In addition, they are utilized to develop novel cell therapies and cell-based treatments for various chronic medical ailments. Besides this, with the onset of coronavirus disease (COVID-19), there has been rapid development of novel vaccines, therapies, and testing kits. This has escalated the demand for cell isolation tools for diagnostics and research activities. Moreover, increasing investments in research and development (R&D) by biotechnology and biopharmaceutical companies to manufacture advanced biologics,such as monoclonal antibodies and vaccines, provide a positive outlook to the market in the near future.
Breakup by Technique:
- Surface Marker
Breakup by Cell Type:
- Human Cells
- Animal Cells
Breakup by Product:
- Reagents, Kits, Media and Sera
- Flow Cytometers
- Filtration Systems
- Magnetic-activated Cell Separator Systems
Breakup by Application:
- Biomolecule Isolation
- Stem Cell Research
- Cancer Research
- Tissue Regeneration
- In-Vitro Diagnostics
Breakup by End Use:
- Biotechnology and Biopharmaceutical Companies
- Hospitals and Diagnostic Laboratories
- Research Laboratories and Institutes
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Alfa Laval AB
- Becton Dickinson and Company
- Beckman Coulter Inc. (Danaher Corporation)
- Bio-Rad Laboratories Inc.
- General Electric Company
- Merck KGaA
- Miltenyi Biotec B.V. & Co. KG
- pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
- Roche Holding AG
- STEMCELL Technologies Inc.
- Terumo Corporation
- Thermo Fisher Scientific Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure:
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal